Blow-by as potential therapy for uncooperative children: An in-vitro study

Respiratory Care

Volumn 57, Issue 12, 2012, Pages 2004-2011

  Mansour, Mohamed Mohsen ^a   Smaldone, Gerald C ^a  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aerosol; Blow by; Budesonide; Nebulizer; Pediatric

Indexed keywords

BUDESONIDE;

AEROSOL; ARTICLE; COMPRESSOR; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FACE MASK; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; NEBULIZER; PEDIATRICS; RESPIRATORY EQUIPMENT;

AEROSOLS; BUDESONIDE; CHILD; COOPERATIVE BEHAVIOR; EQUIPMENT DESIGN; GLUCOCORTICOIDS; HUMANS; MASKS; MATERIALS TESTING; MODELS, ANATOMIC; NEBULIZERS AND VAPORIZERS;

EID: 84870829503     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.01653     Document Type: Article

References (19)

1. Amirav I, Newhouse MT. Aerosol therapy in infants and toddlers: past, present and future. Expert Rev Respir Med 2008;2(5):597-605.
2. Lin HL, Restrepo RD, Gardenhire DS, Rau JL. Effect of face mask design on inhaled mass of nebulized albuterol, using a pediatric breathing model. Respir Care 2007;52(8):1021-1026.
3. Restrepo RD, Dickson SK, Rau JL, Gardenhire DS. An investigation of nebulized bronchodilator delivery using a pediatric lung model of spontaneous breathing. Respir Care 2006;51(1):56-61.
4. Laube BL, Janssens HM, de Jongh FH, Devadason SG, Dhand R, Diot P, et al. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J 2011;37(6):1308-1331.
5. Rubin BK. Bye-bye, blow-by [editorial]. Respir Care 2007;52(8): 981.
6. Sheffer AL, Taggart vs The National Asthma Education Program. Expert panel report guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute. Med Care 1993; 31(3 Suppl):MS20-MS28.
7. Boe J, Dennis JH, O'Driscoll BR, Bauer TT, Carone M, Dautzenberg B, et al. European Respiratory Society Guidelines on the use of nebulizers. Eur Respir J 2001;18(1):228-242.
8. Harris KW, Smaldone GC. Facial and ocular deposition of nebulized budesonide: effects of face mask design. Chest 2008;133(2):482-488.
9. Nikander K, Berg E, Smaldone GC. Jet nebulizers versus pressurized metered dose inhalers with valved holding chambers: effects of the facemask on aerosol delivery. J Aerosol Med 2007;20(Suppl 1):S46-S55; discussion S55-S58
10. Smaldone GC, Cruz-Rivera M, Nikander K. In vitro determination of inhaled mass and particle distribution for budesonide nebulizing suspension. J Aerosol Med 1998;11(2):113-125.
11. Ritson SDJ, Everard ML. Aerosol delivery systems acceptable to young children improve drug delivery (abstract). Thorax 1998;53: A55.
12. Amirav I, Mansour Y, Mandelberg A, Bar-Ilan I, Newhouse MT. Redesigned face mask improves "real life" aerosol delivery for Nebuchamber. Pediatr Pulmonol 2004;37(2):172-177.
13. Esposito-Festen JE, Ates B, van Vliet FJ, Verbraak AF, de Jongste JC, Tiddens HA. Effect of a facemask leak on aerosol delivery from a pMDI-spacer system. J Aerosol Med 2004;17(1):1-6.
14. Murakami G, Igarashi T, Adachi Y, Matsuno M, Sawai M, Yoshizumi A, et al. Measurement of bronchial hyperreactivity in infants and preschool children using a new method. Ann Allergy 1990; 64(4):383-387.
15. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med 1999; 159(9):941-955.
16. Cumming RG, Mitchell P, Leeder SR. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med 1997;337(1):8-14.
17. Geller DE. Clinical side effects during aerosol therapy: cutaneous and ocular effects. J Aerosol Med 2007; 20(Suppl 1):S100-S108; discussion S109.
18. Woelfle J, Zielen S, Lentze MJ. Unilateral fixed dilated pupil in an infant after inhalation of nebulized ipratropium bromide. J Pediatr 2000;136(3):423-424.
19. Bisquerra RA, Botz GH, Nates JL. Ipratropium-bromide-induced acute anisocoria in the intensive care setting due to ill-fitting face masks. Respir Care 2005;50(12):1662-1664.